喵ID:LmwCPR免责声明

Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway.

基本信息

DOI:
10.3389/fphar.2022.921209
发表时间:
2022
影响因子:
5.6
通讯作者:
Jiao, Yang
中科院分区:
医学2区
文献类型:
Journal Article
作者: Liu, Haoge;Pang, Qinglu;Cao, Fang;Liu, Zhaoheng;Wei, Wan;Li, Zhipeng;Long, Qi;Jiao, Yang研究方向: Pharmacology & PharmacyMeSH主题词: --
来源链接:pubmed详情页地址

文献摘要

Number 2 Feibi Recipe (N2FBR) is a traditional Chinese medicine formula for treating idiopathic pulmonary fibrosis. N2FBR inhibits H2O2-mediated oxidative stress damage in alveolar epithelial cells by increasing autophagy, as we previously demonstrated. However, it is unknown if similar mechanisms occur in vivo. We established a pulmonary fibrosis model by instilling bleomycin (BLM) from the airway to examine the effects of N2FBR on pulmonary fibrosis and investigate its probable mechanism in this work. We discovered that N2FBR treatment effectively alleviated interstitial fibrosis as well as collagen deposition, primarily in upregulating SOD, GSH-Px, T-AOC and downregulating MDA content. N2FBR also increased the expression of LC3B, Beclin-1, LAMP1, TFEB and downregulated the expression of p62, legumain. N2FBR treatment boosted the production of autophagosomes, according to the results of the TEM observation. Furthermore, we explored that N2FBR exerted its anti-oxidative stress and pro-autophagy effects via GSK-3β/mTOR signalling pathway. Therefore, these results provide further evidence for the protective effect of N2FBR in pulmonary fibrosis. Our findings could have ramifications for the development of antifibrosis therapies.
二号肺痹方(N2FBR)是一种治疗特发性肺纤维化的中药方剂。正如我们之前所证明的,N2FBR通过增强自噬抑制肺泡上皮细胞中过氧化氢介导的氧化应激损伤。然而,尚不清楚在体内是否存在类似机制。在本研究中,我们通过气道滴注博来霉素(BLM)建立肺纤维化模型,以检验N2FBR对肺纤维化的影响并探究其可能的机制。我们发现N2FBR治疗有效地减轻了间质纤维化以及胶原沉积,主要是通过上调超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH - Px)、总抗氧化能力(T - AOC)以及下调丙二醛(MDA)含量。N2FBR还增加了LC3B、Beclin - 1、LAMP1、TFEB的表达,并下调了p62、 legumain的表达。根据透射电镜(TEM)观察结果,N2FBR治疗促进了自噬体的产生。此外,我们探究发现N2FBR通过GSK - 3β/mTOR信号通路发挥其抗氧化应激和促进自噬的作用。因此,这些结果为N2FBR在肺纤维化中的保护作用提供了进一步的证据。我们的研究结果可能对抗纤维化疗法的发展产生影响。
参考文献(42)
被引文献(6)
Autophagy in idiopathic pulmonary fibrosis.
DOI:
10.1371/journal.pone.0041394
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
Patel AS;Lin L;Geyer A;Haspel JA;An CH;Cao J;Rosas IO;Morse D
通讯作者:
Morse D
Anabolic signaling and protein deposition are enhanced by intermittent compared with continuous feeding in skeletal muscle of neonates
DOI:
10.1152/ajpendo.00516.2011
发表时间:
2012-03-01
期刊:
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
影响因子:
5.1
作者:
El-Kadi, Samer W.;Suryawan, Agus;Davis, Teresa A.
通讯作者:
Davis, Teresa A.
TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target.
TRIB3-GSK-3β 相互作用促进肺纤维化并作为潜在的治疗靶点
DOI:
10.1016/j.apsb.2021.06.017
发表时间:
2021-10
期刊:
Acta pharmaceutica Sinica. B
影响因子:
0
作者:
Liu S;Lv X;Wei X;Liu C;Li Q;Min J;Hua F;Zhang X;Li K;Li P;Xiao Y;Hu Z;Cui B
通讯作者:
Cui B
The impact of TGF-beta on lung fibrosis: from targeting to biomarkers.
DOI:
10.1513/pats.201203-023aw
发表时间:
2012-07-01
期刊:
Proceedings of the American Thoracic Society
影响因子:
0
作者:
Fernandez, Isis E;Eickelberg, Oliver
通讯作者:
Eickelberg, Oliver
LAMP-2 mediates oxidative stress-dependent cell death in Zn2+-treated lung epithelium cells
DOI:
10.1016/j.bbrc.2017.05.030
发表时间:
2017-06-17
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
Qin, Xia;Zhang, Jun;Zou, Zhen
通讯作者:
Zou, Zhen

数据更新时间:{{ references.updateTime }}

关联基金

肺痹汤调控BRP-39/IL-17与TGF-β/ Smad3的交互作用以改善肺纤维化免疫炎性病理损伤
批准号:
81573970
批准年份:
2015
资助金额:
59.0
项目类别:
面上项目
DEVELOPMENT OF HYPOGLYCEMIA IN CHILDREN WITH TYPE 1 DIABETES
批准号:
7202118
批准年份:
2004
资助金额:
2.41
项目类别:
Jiao, Yang
通讯地址:
Chongqing Tradit Chinese Med Hosp, Dept Resp & Crit Care Med, Chongqing, Peoples R China
所属机构:
Chongqing Tradit Chinese Med Hosp
电子邮件地址:
conlong71@126.com
通讯地址历史:
Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China
所属机构
Beijing Univ Chinese Med
Beijing University of Chinese Medicine
Beijing Univ Chinese Med, Dongfang Hosp, Beijing, Peoples R China
所属机构
Beijing Univ Chinese Med
Beijing University of Chinese Medicine
Dongfang Hospital
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓